Anemia in Pregnancy Clinical Trial
Official title:
Once Daily Versus Twice Daily Iron Supplementation to Treat Anemia in Pregnancy: A Prospective, Randomized, Placebo Controlled, Double Blinded, Clinical Trial
The investigators will randomize women diagnosed with anemia in the mid-trimester of pregnancy to once or twice daily iron supplementation
Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03922087 -
No-worry Baby Project
|
||
| Completed |
NCT03175042 -
Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic
|
||
| Terminated |
NCT01193192 -
A Retrospective Analysis of Neevo® and NeevoDHA® Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
|
N/A | |
| Completed |
NCT01062958 -
A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
|
N/A | |
| Completed |
NCT03689218 -
Evidence Generation Related to Stunting Prevention in Balochistan
|
N/A | |
| Withdrawn |
NCT03564756 -
Effect of Ascorbic Acid Supplementation in Pregnancy on Anemia (AAA)
|
N/A |